Artificial intelligence: opportunities in lung cancer

Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes

Lung cancer remains one of the leading causes of cancer-related deaths worldwide, emphasizing the need for improved diagnostic and treatment approaches. In recent years, the emergence of artificial intelligence (AI) has sparked considerable interest in its potential role in lung cancer. This review aims to provide an overview of the current state of AI applications in lung cancer screening, diagnosis, and treatment. AI algorithms like machine learning, deep learning, and radiomics have shown remarkable capabilities in the detection and characterization of lung nodules, thereby aiding in accurate lung cancer screening and diagnosis. These systems can analyze various imaging modalities, such as low-dose CT scans, PET-CT imaging, and even chest radiographs, accurately identifying suspicious nodules and facilitating timely intervention. AI models have exhibited promise in utilizing biomarkers and tumor markers as supplementary screening tools, effectively enhancing the specificity and accuracy of early detection. These models can accurately distinguish between benign and malignant lung nodules, assisting radiologists in making more accurate and informed diagnostic decisions. Additionally, AI algorithms hold the potential to integrate multiple imaging modalities and clinical data, providing a more comprehensive diagnostic assessment. By utilizing high-quality data, including patient demographics, clinical history, and genetic profiles, AI models can predict treatment responses and guide the selection of optimal therapies. Notably, these models have shown considerable success in predicting the likelihood of response and recurrence following targeted therapies and optimizing radiation therapy for lung cancer patients. Implementing these AI tools in clinical practice can aid in the early diagnosis and timely management of lung cancer and potentially improve outcomes, including the mortality and morbidity of the patients.

Context-aggregator: An approach of loss- and class imbalance-aware aggregation in federated learning

Federated Learning (FL) is an emerging distributed learning paradigm which offers data privacy to contributing nodes in the collaborating environment. By exploiting the Individual datasets of different hospitals in FL setting could be used to develop reliable screening, diagnosis, and treatment predictive models to tackle major challenges such as pandemics. FL can enable the development of very diverse medical imaging datasets and thus provide more reliable models for all participating nodes, including those with low quality data. However, the issue with the traditional Federated Learning paradigm is the degradation of generalization power due to poorly trained local models at the client nodes. The generalization power of the FL paradigm can be improved by considering the relative learning contribution of client nodes. Simple aggregation of learning parameters in the standard FL model faces a diversity issue and results in more validation loss during the learning process. This issue can be resolved by considering the relative contribution of each client node participating in the learning process. The class imbalance at each site is another significant challenge that greatly impacts the performance of the aggregated learning model. This work considers Context Aggregator FL based on the context of loss-factor and class-imbalance issues by incorporating the relative contribution of the collaborating nodes in FL by proposing Validation-Loss based Context Aggregator (CAVL) and Class Imbalance based Context Aggregator (CACI). The proposed Context Aggregator is evaluated on several different Covid-19 imaging classification datasets present on participating nodes. The evaluation results show that Context Aggregator performs better than standard Federating average Learning algorithms and FedProx Algorithm for Covid-19 image classification problems.

Mapping intellectual structures and research hotspots in the application of artificial intelligence in cancer: A bibliometric analysis

Background

Artificial intelligence (AI) is more and more widely used in cancer, which is of great help to doctors in diagnosis and treatment. This study aims to summarize the current research hotspots in the Application of Artificial Intelligence in Cancer (AAIC) and to assess the research trends in AAIC.

Methods

Scientific publications for AAIC-related research from 1 January 1998 to 1 July 2022 were obtained from the Web of Science database. The metrics analyses using bibliometrics software included publication, keyword, author, journal, institution, and country. In addition, the blustering analysis on the binary matrix was performed on hot keywords.

Results

The total number of papers in this study is 1592. The last decade of AAIC research has been divided into a slow development phase (2013-2018) and a rapid development phase (2019-2022). An international collaboration centered in the USA is dedicated to the development and application of AAIC. Li J is the most prolific writer in AAIC. Through clustering analysis and high-frequency keyword research, it has been shown that AI plays a significantly important role in the prediction, diagnosis, treatment and prognosis of cancer. Classification, diagnosis, carcinogenesis, risk, and validation are developing topics. Eight hotspot fields of AAIC were also identified.

Conclusion

AAIC can benefit cancer patients in diagnosing cancer, assessing the effectiveness of treatment, making a decision, predicting prognosis and saving costs. Future AAIC research may be dedicated to optimizing AI calculation tools, improving accuracy, and promoting AI.